TThe company is in the process of developing the Bioequivalence (BE) and Pharmaceutical Equivalence (PE) studies for the next phase of dossiers to be submitted in the areas of -
As this subsidiary is still in the process of being incorporated and while they have thought out the site for the facility, the office address will be made available, once the incorporation procedure is complete.
+91 40 30438600